2nd Quarter - Report

PFIZER INC. for PFIZER INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,940,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 20, 2018 $1,940,000 Replaced
2nd Quarter - Amendment Jul 25, 2018 $1,940,000 Replaced
2nd Quarter - Amendment Oct 21, 2018 $1,950,000 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Comprehensive Corporate Tax Reform

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
CAROLINE MOODY SCHELLHAS —

Contacted: Patent & Trademark Office (PTO); Office of the Vice President of the United States; Natl Security Council (NSC); White House Office; U.S. Trade Representative (USTR); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); SENATE; Food & Drug Administration (FDA); Natl Economic Council (NEC); Executive Office of the President (EOP); Treasury, Dept of; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Creates Act Patent Settlements Transferable exclusivity

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
EMILY MUELLER New Legislative Correspondent; Legislative Assistant; Legislative Director; Senior Health Policy Advisor; Deputy Legislative Director
ANGELA WALKER RIEMER —

Contacted: Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); Patent & Trademark Office (PTO); Executive Office of the President (EOP); Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); White House Office; SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); State, Dept of (DOS); Office of the Vice President of the United States

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill Trans-Atlantic trade & Investment Partnership Canada IP/Trade Issues South Africa IP Issues China IP Indonesia IP Thailand IP Korea Pricing Issues United Nations Health Panel G7/G20 APEC OECD Australia Market - Size Damages WTO "Zero for Zero" Pharmaceutical Agreement NAFTA

LobbyistCovered position, as disclosed
DOUGLAS REID GOUDIE —

Contacted: Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Natl Security Council (NSC); Natl Economic Council (NEC); Patent & Trademark Office (PTO); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; Commerce, Dept of (DOC); Food & Drug Administration (FDA); State, Dept of (DOS); Health & Human Services, Dept of (HHS); SENATE; White House Office; U.S. Trade Representative (USTR)

Alcohol and Drug Abuse ALC

Prescription Drug Abuse

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES —
EMILY MUELLER New Legislative Correspondent; Legislative Assistant; Legislative Director; Senior Health Policy Advisor; Deputy Legislative Director
ANGELA WALKER RIEMER —

Contacted: White House Office; U.S. Trade Representative (USTR); Treasury, Dept of; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Office of the Vice President of the United States; Natl Economic Council (NEC); Commerce, Dept of (DOC); State, Dept of (DOS); Natl Security Council (NSC); SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare Part D Coverage Gap Biosimilar pass-through

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
ANGELA WALKER RIEMER —

Contacted: Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); SENATE; Natl Security Council (NSC); Treasury, Dept of; State, Dept of (DOS); Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); White House Office; U.S. Trade Representative (USTR); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018 Omnibus Appropriations Act of 2018

LobbyistCovered position, as disclosed
PAULA BURG —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
ANGELA WALKER RIEMER —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Office of the Vice President of the United States; Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); White House Office; Commerce, Dept of (DOC); State, Dept of (DOS); Natl Security Council (NSC); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Executive Office of the President (EOP)

Health Issues HCR

Drug Pricing Biosimilars Reimbursement Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ROBERT JONES New —
EMILY MUELLER New Legislative Correspondent; Legislative Assistant; Legislative Director; Senior Health Policy Advisor; Deputy Legislative Director
ANGELA WALKER RIEMER —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Office of the Vice President of the United States; Patent & Trademark Office (PTO); Treasury, Dept of; SENATE; Natl Economic Council (NEC); Executive Office of the President (EOP); Natl Security Council (NSC); Food & Drug Administration (FDA); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.